Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could less steroids be better for Immunotherapy-Related liver issues?

NCT ID NCT05345847

First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 17 times

Summary

This study looks at whether closely watching and only using steroids when needed is as safe and effective as giving high-dose steroids right away for liver inflammation caused by cancer immunotherapy. About 56 adults with grade 2 or 3 liver inflammation will be randomly assigned to one of two approaches. The goal is to see if the steroid-sparing method can control the inflammation without causing more serious liver problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS IMMUNE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Arthur J.E. Child Comprehensive Cancer Centre

    RECRUITING

    Calgary, Alberta, T2N 5G2, Canada

    Contact

Conditions

Explore the condition pages connected to this study.